The c-Jun N-terminal kinases (JNKs) (also called stressactivated protein kinases) are mitogen-activated protein kinases (MAPKs) that are activated by stress stimuli, such as growth factor withdrawal and UV irradiation, and which function to communicate growth-inhibitory and apoptotic signals within cells (11, 14, 23) . Members of the JNK family phosphorylate and activate members of the AP-1 group of transcription factors (c-Jun, JunB, and JunD) and the AP-1-related transcription factor ATF2, events which are likely to mediate, at least in part, the effects of JNK signaling pathways (9) .
Gene disruption studies have shown that JNK is required for the release of proapoptotic molecules from the mitochondria in response to UV irradiation, indicating a role for JNK in mitochondrial pathways of apoptosis, although the exact mechanisms by which JNK facilitates this process remain incompletely understood (39) . Mitochondrial apoptotic pathways are regulated by the Bcl-2 family of proteins. During mitochondrion-dependent apoptosis, the proapoptotic multidomain Bcl-2 family members (Bax and Bak) undergo a conformational change and redistribute from the cytoplasm to the mitochondria, where they are thought to mediate the release of proapoptotic molecules, including cytochrome c and Smac (15) . The finding that Bax and Bak are essential for JNKstimulated release of cytochrome c and apoptosis suggests that JNK influences mitochondrial apoptotic pathways through Bcl-2 family proteins (26) .
Reovirus is a double-stranded RNA virus that induces apoptosis both in cultured cells and in target tissues (6) . In the central nervous system and heart, virus-induced apoptosis correlates with pathology and is a critical mechanism by which disease is triggered in the host (10, 27, 32) . In a variety of human epithelial cell lines and in primary neuronal cultures, reovirus-induced apoptosis is mediated by death ligands, including tumor necrosis factor, tumor necrosis factor-related apoptosis-inducing ligand, and Fas ligand (3, 4, 32) . Ligand binding induces the activation of the initiator caspase, caspase 8, and the subsequent activation of the effector caspases (3, 20) . Mitochondrial apoptotic pathways are also activated following reovirus infection by the caspase 8-dependent cleavage of Bid (20, 21) . Consequently, reovirus-induced apoptosis is inhibited by overexpression of Bcl-2 (33) , which blocks the release of proapoptotic mitochondrial factors, including cytochrome c and Smac, and the activation of caspase 3 in reovirusinfected cells (21) . Although both Smac and cytochrome c function to promote caspase 3 activity, it is the release of Smac and the subsequent inhibition of cellular inhibitors of apoptosis that play the most significant role during reovirus-induced apoptosis (21) .
We have shown that JNK and its associated transcription factor, c-Jun, are activated following reovirus infection and that JNK activation is mediated by MEK kinase I (MEKK1) (43) . Activation of JNK and c-Jun are associated with reovirusinduced apoptosis (5). Thus, apoptotic viral strains induce the activation of JNK and c-Jun, whereas nonapoptotic viral strains do not (5) . In addition, strain-specific differences in JNK activation are determined by the reovirus S1 and M2 gene segments, which encode viral outer capsid proteins (1 and 1c) involved in receptor binding and host cell membrane penetration (5) . These same gene segments also determine differences in the capacity of reovirus strains to induce apoptosis (40, 41) . We now show that inhibition of JNK activity inhibits apoptosis in reovirus-infected cells. In contrast, inhibition of c-Jun does not affect reovirus-induced apoptosis, and c-Jun phosphorylation does not correlate with apoptosis in reovirus-infected cells. We further show that JNK inhibition delays the release of the proapoptotic mitochondrial factors Smac and cytochrome c from the mitochondria of infected cells. This report represents the first demonstration of JNKinduced regulation of mitochondrial apoptotic pathways in virus-infected cells.
MATERIALS AND METHODS
Cells and virus. HEK293 cells (ATCC CRL1573) were grown in Dulbecco's modified Eagle's medium supplemented with 100 U each of penicillin and streptomycin/ml and containing 10% fetal bovine serum. HeLa cells (ATCC CCL2) were grown in Eagle's minimal essential medium supplemented with 2.4 mM L-glutamine, nonessential amino acids, and 60 U each of penicillin and streptomycin/ml and containing 10% fetal bovine serum (Gibco BRL). MEKK1
Ϫ/Ϫ and wild-type (WT) embryonic stem (ES) cells and HEK293 cells expressing kinaseinactive MEK kinase 1, MEKK1KM (13), have previously been described. Reovirus strain type 3 Abney was used for all experiments. Reovirus strain type 3 Abney is a laboratory stock that has been plaque purified and passaged (twice) in L929 (ATCC CCL1) cells to generate working stocks. Virus infections and growth assays were performed as previously described (3, 41) . Adenovirus expressing dominant-negative (DN) c-Jun (28) was provided by K. Heidenreich (University of Colorado).
Reagents. JNK inhibitor I (JNKI1) was obtained from Alexis, and JNK inhibitor II (420119), PD98059 (MEK inhibitor), and SB203580 (p38 inhibitor) were purchased from Calbiochem. Each inhibitor was used at a concentration of 10 M. Cells were pretreated with inhibitors for 2 h before viral infection and were added back to media following infection.
Apoptosis assays. Cells were assayed for apoptosis by staining them with acridine orange, for determination of nuclear morphology, and ethidium bromide, to distinguish cell viability, at a final concentration of 1 g/ml each. Following staining, cells were examined by epifluorescence microscopy (Labophot-2: B-2A filter, excitation, 450 to 490 nm; barrier, 520 nm; dichroic mirror, 505 nm; Nikon). The percentage of cells containing condensed nuclei and/or marginated chromatin in a population of 100 cells was recorded. The specificity of this assay has been previously established with reovirus-infected cells by using DNA laddering techniques and electron microscopy (4, 41) .
Caspase 3 activity assays. Caspase 3 activation assays were performed by using a kit obtained from Clontech. Cells (10 6) were centrifuged at 200 ϫ g for 10 min, supernatants were removed, and cell pellets were frozen at Ϫ70°C until collections were made for all time points. Assays were performed with 96-well plates, and analysis was done by using a fluorescence plate reader (CytoFluor 4000; PerSeptive Biosystems). Cleavage of DEVD-AFC, a synthetic caspase-3 substrate, was used to measure caspase 3 activation in reovirus-infected cells. Cleavage after the second Asp residue produces free AFC that can be detected using a fluorescence plate reader. The amount of fluorescence detected is directly proportional to the amount of caspase 3 activity.
Western blot analysis. Following infection with reovirus, cells were pelleted by centrifugation and washed twice with ice-cold phosphate-buffered saline (PBS). For whole-cell extracts, the cell pellet was lysed by sonication in 150 l of a buffer containing 1% Triton X-100, 10 mM triethanolamine-HCl, 150 mM NaCl, 5 mM EDTA (pH ϭ 8.0), 1 mM phenylmethylsulfonyl fluoride, and 2.5 l of 25ϫ complete protease inhibitor cocktail mix (catalog no. 1-697-498; Roche)/ml. The lysates were then cleared by centrifugation at 14,000 ϫ g for 3 min, mixed 1:1 with 2ϫ Laemmli buffer (catalog no. S-3401; Sigma), boiled for 5 min, and stored at Ϫ70°C. For mitochondrial extracts, the cell pellet was resuspended in 300 l of a buffer containing 220 mM mannitol, 68 mM sucrose, 50 mM piperazine-N, NЈ-bis(2-ethanesulfonic acid)-KOH (pH ϭ 7.4), 50 mM KCl, 5 mM EGTA, 2 mM MgCl 2 , and 1 mM dithiothreitol. The resuspended pellet was incubated on ice for 30 min and then homogenized with a B-pestle in a 2-ml dounce homogenizer for 40 strokes. The lysates were then cleared by centrifugation at 14,000 ϫ g for 15 min. The supernatant, the mitochondrium-free fraction, was mixed 1:1 with 2ϫ Laemmli Buffer (Sigma catalog no. S-3401), boiled for 5 min, and stored at Ϫ70°C. The pellet, the cytoplasmic fraction, was then lysed by sonication in 100 l of whole-cell lysis buffer (above), mixed 1:1 with 2ϫ Laemmli buffer, boiled for 5 min, and stored at Ϫ70°C.
Proteins were electrophoresed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, either through 10% Tris-tricine gels (phospho-c-Jun and c-Jun) or through 15% Tris-tricine gels (Smac and cytochrome c), and probed with antibodies directed against phospho-c-Jun (catalog no. 9261; 1:1,000 in 1% nonfat dry milk-Tris-buffered saline [TBS]; Cell Signaling), c-Jun (catalog no. 9162; 1:1,000 in 1% nonfat dry milk-TBS; Cell Signaling), Smac (catalog no. 567365; 1:1,000 in 1% nonfat dry milk-TBS; Calbiochem), and cytochrome c (catalog no. 556433; 1:1,000 in 1% nonfat dry milk-TBS; BD Pharmingen). All lysates were standardized for protein concentration with antibodies directed against actin (catalog no. CP-01; 1:10,000 in 1% nonfat dry milk-TBS; Calbiochem).
Immunocytochemistry. Cells were plated in eight-well chamber slides. After infection, cells were fixed (3.7% formaldehyde-PBS) for 30 min at room temperature (RT). Cells were then washed with PBS and made permeable with PBS-0.1% Triton X-100 (PBSX) for 1 h at RT, blocked in 5% bovine serum albumin-PBSX for 2 h at RT, and then incubated overnight (4°C) with primary antibody (1:100) in 3% bovine serum albumin-PBSX. Primary antibodies used were directed against cleaved (active) caspase 3 (catalog no. 9661L; Cell Signaling). Following incubation, cells were washed three times (3 min each wash) with PBSX before being incubated with antirabbit or antirat immunoglobulin G conjugated with fluorescein isothiocyanate (1:100) for 1 h at RT. Fluorescent immunoglobulin Gs were obtained from Vector Laboratories. Incubation with secondary antibody and all subsequent steps were performed in the dark. Cells were then washed with PBSX (three times, 3 min each wash), incubated for a further 5 min with Hoechst-PBS (1:1000; Molecular Probes), washed again with PBSX (three times, 3 min each wash), and mounted with Vectashield (Vector Laboratories). After mounting, slides were sealed with clear nail polish and stored at 4°C. Labeling of mitochondria was performed using Cy3-labeled streptavidin (ImmunoResearch Laboratories) for 15 to 20 min prior to Hoechst staining.
RESULTS

MEKK1 is required for reovirus-induced apoptosis.
Reovirus-induced activation of JNK and c-Jun is associated with apoptosis in infected cells (5) . We have shown that MEKK1 acts as an upstream activator of JNK signaling (43) . We thus investigated the role of MEKK1 in reovirus-induced apoptosis. MEKK1 Ϫ/Ϫ mouse embryo fibroblasts were infected with reovirus (multiplicity of infection[MOI], 10). At 48 h postinfection (p.i.), 48% of reovirus-infected wild-type (WT) cells contained apoptotic nuclei (Fig. 1A) . This number was significantly reduced (P Ͻ 0.05) to 11% in MEKK1 Ϫ/Ϫ cells (Fig.  1A) . We next looked at reovirus-induced activation of caspase 3 in MEKK1 Ϫ/Ϫ cells, using fluorogenic substrate assays. In WT cells, increases in caspase 3 activity were seen as early as 18 h p.i. and peaked at 30 h p.i., after which times levels remained high (Fig. 1B) . In contrast, there was no increase in caspase 3 activity in MEKK1
Ϫ/Ϫ cells following reovirus infection. Reovirus-induced apoptosis was also investigated in HEK293 cells expressing a kinase-inactive form of MEKK1 (MEKK1KM). Cells were infected with reovirus (MOI of 100). Forty-eight hours p.i., reovirus induced 65% apoptosis in cells expressing vector alone. This was significantly (P Ͻ 0.05) reduced to 20% in cells expressing MEKK1KM (Fig. 1C) . These results indicate that reovirus-induced apoptosis is inhibited in MEKK1 Ϫ/Ϫ cells and in cells expressing MEKK1KM, compared to the case with controls expressing WT MEKK1.
JNK is required for efficient apoptosis in reovirus-infected cells. Having shown that reovirus-induced apoptosis requires MEKK1 and is inhibited in MEKK1
Ϫ/Ϫ cells, which show reduced reovirus-induced JNK activation (43), we next investigated the effects of specific JNK inhibitors on reovirus-induced apoptosis. Two different inhibitors were used. The first, JNKI1, is a peptide inhibitor that blocks JNK binding to its substrate, and the second, JNK inhibitor II, inhibits JNK kinase activity. Since both HEK293 cells and HeLa cells have been used extensively in the analysis of reovirus-induced apoptosis, we used both of these cell lines in our experiments. Cells were treated with JNK inhibitors for 2 h before being infected with reovirus at a MOI of 10 or 100. Cells were harvested 24 and 48 h p.i., and the percentage of cells with apoptotic nuclear morphology was determined ( Fig. 2A and B) . In HEK293 cells, an inhibitor (16, 24, 34) and the antiapoptotic extracellular signal-related kinases (ERK) (7) had no effect on reovirus-induced apoptosis ( Fig. 2A and B) , as previously shown (5). These results indicate that JNK, but not P38 or ERK, is required for efficient apoptosis in reovirus-infected HEK293 cells. Apoptosis in mockinfected cells, with or without inhibitor, was less than 5%. A similar effect on apoptosis was seen after treatment of HeLa cells with JNK and ERK inhibitors (data not shown). However, an inhibitor of P38 was able to reduce reovirus-induced apoptosis in these cells at 24 h p.i. (data not shown).
The effect of JNK inhibition on apoptosis was also investigated by immunocytochemistry, using antibody directed against the cleaved (active) form of caspase 3. HeLa cells were incubated with JNKI1 for 2 h before being infected with reovirus. Cells were then incubated for a further 18 h before immunocytochemistry was performed (Fig. 2C) . Active caspase 3 staining was seen in 39% of cells infected with reovirus, compared to 3% of mock-infected controls. Activation of caspase 3 was significantly (P Ͻ 0.001) reduced in the presence of JNKI1. These experiments suggest that JNK activity is required for efficient apoptosis and activation of caspase 3 in reovirus-infected cells.
The observed differences in the ability of reovirus to induce apoptosis were not caused by differences in viral growth, since one-step growth curves indicated that reovirus grows efficiently and equivalently in HEK293 cells in the presence or absence of JNKI1 (Fig. 2D) .
c-Jun activation is not required for reovirus-induced apoptosis. JNK activates members of the AP-1 group of transcription factors, including c-Jun, JunB, and JunD (9) . We have previously shown that c-Jun is activated after reovirus infection, and this activation has been associated with reovirusinduced apoptosis. In other systems, JNK has been shown to influence apoptosis by its ability to activate the AP-1 transcription factor. We therefore investigated the role of AP-1 in reovirus-induced apoptosis. First, the role of MAPKs, including JNK, in c-Jun phosphorylation was determined in reovirusinfected cells. c-Jun is activated by 12 h p.i. in reovirus-infected HEK293 cells, and activation peaks around 18 h p.i. (5) . We therefore investigated c-Jun phosphorylation in reovirus-infected HEK293 cells at 18 h p.i. in the presence or absence of inhibitors of JNK binding and P38 and ERK activity. Cells were pretreated with inhibitor for 2 h prior to infection (MOI of 100). Eighteen hours p.i., cells were harvested and screened by Western blot analysis for the presence of both the phosphorylated (active) and nonphosphorylated form of c-Jun. Reovirus infection resulted in the phosphorylation of c-Jun (Fig.  3A) , as has previously been shown (5) . The detection of multiple bands by the c-Jun antibodies indicates the multiple phosphorylation sites present on the c-Jun protein. Reovirus-induced activation of c-Jun was partially blocked by inhibition of JNK or ERK and was completely blocked when both JNK and ERK inhibitors were used together. In contrast, an inhibitor of P38 appeared to increase c-Jun phosphorylation after reovirus infection (Fig. 3A) . Levels of total c-Jun indicated that reovirus also induced an increase in levels of total c-Jun in HEK293 cells (Fig. 3A) . The presence of multiple bands again indicated that c-Jun was phosphorylated at multiple sites following reovirus infection. Increased c-Jun levels were not affected by These results indicate that JNK and ERK, but not P38, contribute to c-Jun activation following reovirus infection. They also suggest that c-Jun activation does not correlate with apoptosis in reovirus-infected cells, since JNK inhibition reduces c-Jun phosphorylation and decreases apoptosis, ERK inhibition reduces c-Jun phosphorylation and has no effect on apoptosis, and P38 inhibition increases c-Jun phosphorylation yet has no effect on apoptosis in HEK293 cells and decreases apoptosis in HeLa cells (Fig. 3B) .
To conclusively determine the role of c-Jun/AP-1 in reovirus-induced apoptosis, we used adenovirus expressing domi- under the control of the cytomegalovirus promoter and were incubated for 36 h to allow expression of the DN c-Jun phenotype. Cells were then infected with reovirus (MOI of 10 and 100) for 48 h before being harvested. Reovirus infection at both a MOI of 10 and a MOI of 100 resulted in apoptosis (42 and 67%, respectively) in HEK293 cells that had not been previously treated with adenovirus (Fig. 4A) . Reovirus induced apoptosis was not affected by treatment with adenovirus expressing either GFP or DN c-Jun (Fig. 4A) . In contrast, anisomycin-induced apoptosis, which requires c-Jun, was reduced in HEK293 cells infected with adenovirus expressing DN c-Jun (Fig. 4B) , indicating that c-Jun expression is not required for reovirus-induced apoptosis and suggesting that JNK exerts its proapoptotic effects in reovirus-infected cells through an alternate mechanism. JNK is required for efficient release of Smac and cytochrome c after reovirus infection. JNK is required for the release of proapoptotic molecules from the mitochondria in response to UV irradiation (39) . Reovirus also activates mitochondrial apoptotic pathways following infection, resulting in the release of the proapoptotic mitochondrial factors cytochrome c and Smac (21) . We thus investigated the role of JNK in the release of Smac and cytochrome c from the mitochondria during reovirus-induced apoptosis. HeLa cells were incubated with JNKI1 for 2 h before being infected with reovirus. Cells were then harvested at 8 and 24 h p.i. Mitochondrial pellet and mitochondrion-free fractions were prepared and analyzed by Western blot analysis, using antibodies directed against Smac and cytochrome c. Reovirus induced the release of both Smac and cytochrome c from the mitochondria of infected cells (Fig. 5A), as previously described (20, 21) . Levels of Smac and cytochrome c thus dropped in mitochondrial pellet fractions and rose in mitochondrion-free fractions. JNKI1 delayed the release of both mitochondrial Smac and cytochrome c following reovirus infection.
DISCUSSION
We have previously shown that reovirus-induced activation of JNK and its associated transcription factor, c-Jun, is associated with reovirus-induced apoptosis (5) . We now show that reovirus-induced apoptosis is blocked in MEKK1
Ϫ/Ϫ cells, in which reovirus-induced JNK activation is inhibited (43) , and in cells in which MEKK1 kinase activity is blocked. In addition, specific inhibitors of JNK that block JNK-substrate binding or kinase activity block reovirus-induced apoptosis at a low MOI and significantly delay reovirus-induced apoptosis at a high MOI. These results indicate that JNK is required for efficient apoptosis in reovirus-infected cells (Fig. 6) . The more-effective reduction in apoptosis seen in MEKK1
Ϫ/Ϫ cells and cells expressing MEKK1KM compared to that in cells treated with an inhibitor of JNK suggests that MEKK1 may influence reovirusinduced apoptosis by JNK-independent, as well as JNK-dependent, pathways. Inhibition of P38 had no effect on reovirusinduced apoptosis in HEK293 cells, as has been previously shown (5) . However, in HeLa cells, P38 inhibition decreased reovirus-induced apoptosis, suggesting cell type differences in MAPK involvement in reovirus-induced apoptosis. In contrast, inhibition of ERK had no effect on reovirus-induced apoptosis in either cell line, indicating specificity in the role of MAPKs in reovirus-induced apoptosis.
It is possible that JNK regulation of the AP-1 transcription factor mediates, in part, the effects of JNK signaling pathways (9) . JNK-mediated regulation of AP-1 has been reported to increase the expression of the BH3-only proteins Bim and HRK, which are critical for Bax-dependent cytochrome c release, caspase activation, and apoptosis in neurons (17, 30, 42) , although in fibroblasts JNK does not increase Bim expression (25) . To investigate the role of AP-1 in reovirus-induced apoptosis, we used adenovirus expressing DN c-Jun (TAM67), which prevents formation of a functional AP-1 transcription factor (28) . Our studies indicate that expression of DN c-Jun does not block reovirus-induced apoptosis in fibroblasts. The expression of Bim also remains unaltered in reovirus-infected cells (data not shown). In addition, c-Jun phosphorylation does not correlate with reovirus-induced apoptosis. These results indicate that JNK-mediated activation of the c-Jun/AP-1 transcription factor is not required for reovirus-induced apoptosis and that other JNK-dependent pathways are involved.
We have previously demonstrated that caspase 8 activity is required for cleavage of the proapoptotic Bcl-2 family member, Bid, following reovirus infection (20) . We now show that JNK activity is also required for the efficient release of the proapoptotic mitochondrial factors Smac and cytochrome c following reovirus infection. Since JNK activity in reovirusinfected cells does not appear to require death receptor signaling (5), caspase 8-dependent cleavage of Bid and the subsequent redistribution of Bcl-2 family proteins in the mitochondrial membrane provide a mechanism for Smac and cytochrome c release in the presence of JNKI1 (Fig. 6) .
Apoptosis is a mechanism used by the host as part of the antiviral response, and deregulation of this host-pathogen interaction can alter the course of viral replication and explain aspects of viral disease. It is not surprising that many viruses have evolved to manipulate cellular apoptotic pathways. In many cases, inhibition of apoptosis by viruses serves to prevent premature death of the host cell. Inhibitors of apoptosis also may enhance virus production, enable efficient emergence from latency, facilitate persistent infection, and contribute to the avoidance of immune surveillance (8) . Since mitochondrial apoptotic pathways are activated following infection with a wide variety of viruses, including human immunodeficiency virus (12, 18, 19) , influenza A virus (2), herpes simplex virus 1 (44), human herpesvirus 8 (35), hepatitis B virus (38) , and West Nile virus (29) , and since many forms of virus-induced apoptosis are inhibited by antiapoptotic members of the Bcl-2 family (1, 31, 36, 37), a common method of viral inhibition of apoptosis is the expression of viral homologs of Bcl-2 (8) or the induction of antiapoptotic members of the Bcl-2 family (22) .
In addition to contributing to the host's antiviral response, apoptosis can also influence viral pathogenesis and may facilitate rapid virus release and cell-to cell spread. Reovirusinduced apoptosis requires both death receptor and mitochondrial apoptotic pathways (6). Here we show that efficient activation of mitochondrial apoptotic pathways in reovirusinfected cells requires JNK. This is the first report linking JNK to the activation of mitochondrial apoptotic pathways in virusinfected cells. Since the proapoptotic Bcl-2 proteins Bax and Bak are essential for JNK-stimulated release of cytochrome c and apoptosis (26) , further investigation of reovirus-induced mitochondrial apoptotic pathways may provide valuable insight into the pathogenesis of viruses that utilize Bcl-2 family proteins to promote apoptosis (22) or that are blocked by the overexpression of Bcl-2 (1, 31, 36, 37) . 
